Man Group
TRDA icon

Man Group’s Entrada Therapeutics TRDA Stock Holding History

Man Group’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,805
Closed -$113K – 2474
2025
Q2 		$113K Buy
+16,805
New +$135K ﹤0.01% 2116
2024
Q3 		– Sell
-17,249
Closed -$246K – 2206
2024
Q2 		$246K Buy
17,249
+440
+3% +$6.25K ﹤0.01% 1836
2024
Q1 		$238K Buy
+16,809
New +$238K ﹤0.01% 1980
2023
Q3 		– Sell
-14,466
Closed -$219K – 2151
2023
Q2 		$219K Buy
+14,466
New +$199K ﹤0.01% 1802
2023
Q1 		– Hold
0
– – – 1853

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return